XML 16 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]    
Service revenue, net $ 1,702 $ 2,101
Clinical research grants 278  
Other 53  
Revenue, net of contractual allowances and adjustments 2,033 2,101
less allowance for doubtful accounts (310) (378)
Net sales 1,723 1,723
Service revenues 1,317 970
Clinical research grants 114  
Total cost of sales 1,431 970
Gross profit (loss) 292 753
OPERATING EXPENSES:    
Operating expenses 6,488 2,465
Impairment of goodwill 9,315  
TOTAL OPERATING EXPENSES 15,803 2,465
OPERATING LOSS (15,511) (1,712)
OTHER INCOME (EXPENSE):    
Interest expense, net (2,324) (518)
Warrant revaluation (226)  
Loss on extinguishment of debt and induced conversion of convertible bridge notes (1,391)  
Gain on settlement liability, net 877  
Gain on troubled debt restructuring 1,181  
Loss on settlement of equity instrument (624)  
Merger advisory fees (2,676)  
Other, net   3
Other Income (Expense) (5,183) (515)
LOSS BEFORE INCOME TAXES (20,694) (2,227)
INCOME TAX EXPENSE
NET LOSS (20,694) (2,227)
DEEMED DIVIDENDS ON ISSUANCE OR EXCHANGE OF PREFERRED UNITS (12,431) (1,422)
PREFERRED DIVIDENDS (84) (433)
TOTAL DIVIDENDS (12,515) (1,855)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (33,209) $ (4,082)
BASIC AND DILUTED LOSS PER COMMON SHARE (IN DOLLARS PER SHARE) $ (7.16) $ (9.44)
BASIC AND DILUTED WEIGHTED-AVERAGE SHARES OF COMMON STOCK OUTSTANDING (IN SHARES) 4,639,226 432,582